050575s040s042
(amoxicillin/clavulanate potassium). Powder for Oral Suspension and Chewable Tablets. To reduce the development of drug-resistant bacteria and maintain the
Draft Guidance on Amoxicillin and Clavulanate Potassium. Recommended Sept 2019. This draft guidance when finalized
Guidance on Amoxicillin; Clavulanate Potassium. This guidance represents the Food and Drug Administration's (FDA's) current thinking on this topic.
050720s022lbl.pdf
Guidance on Amoxicillin and Clavulanate Potassium. Finalized Aug 2017. This guidance represents the current thinking of the Food and Drug Administration
01-Feb-2012 Amoxicillin and Clavulanate Potassium. CU. = nominal concentration of amoxicillin in the for Oral Suspension. Sample solution (mg/mL).
01-Mar-2009 Amoxicillin and Clavulanate Potassium. Mar-2009). Uniformity of dosage units ?905?: meet the requirements for. Tablets.
amoxicillin and clavulanate potassium for oral suspension and other antibacterial drugs suspension
If you want to discuss an alternative approach contact the Office of Generic Drugs. Active ingredient: Amoxicillin; Clavulanate Potassium. Form/Route: Chewable